Method of stimulation of immune response with low doses of IL-2
US6045788A · kind A · utility
24Cited by
6References
60Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Feb 28, 1996 |
| Grant date | Apr 4, 2000 |
| Priority date | — |
| Expiry date | Feb 28, 2016 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/2013
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of activating the immune system of a subject comprises the chronic administration of low doses of an agent such as IL-2, fusion proteins thereof and derivatives thereof that are pharmaceutically acceptable. The agent is provided as a dermal composition, transdermal delivery device and electrotransport device as well as in the form of a kit for self-administration.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.